Loading...
Docoh

Lipocine (LPCN)

46 patents

Page 2 of 3
Utility
High-strength testosterone undecanoate compositions
12 Oct 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 16 Apr 18
Utility
Pharmaceutical Compositions and Dosage Forms for Administration of Hydrophobic Drugs
9 Sep 20
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs, particularly steroids, are provided.
Feng-Jing Chen, Mahesh V. Patel, David T. Fikstad, Huiping Zhang, Chandrashekar Gilyar
Filed: 12 Mar 20
Utility
High-strength Testosterone Undecanoate Compositions
29 Jul 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Apr 20
Utility
High-strength Testosterone Undecanoate Compositions
29 Jul 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Apr 20
Utility
High-strength Testosterone Undecanoate Compositions
22 Jul 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Apr 20
Utility
High-strength testosterone undecanoate compositions
20 Jul 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 23 Apr 18
Utility
Composition and Method for Oral Delivery of Androgen Prodrugs
15 Jul 20
Provided oral testosterone undecanoate compositions can be administered to hypogonadal males with a meal without the fat content of the meal substantially effecting bioavailability.
Mahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari
Filed: 23 Dec 19
Utility
Oral Testosterone Tridecanoate Therapy
15 Jul 20
The present disclosure provides methods and compositions for testosterone replacement therapy.
Nachiappan Chidambaram, Satish Kumar Nachaegari, Mahesh V. Patel, Kilyoung Kim
Filed: 25 Dec 19
Utility
17-hydroxyprogesterone ester-containing oral compositions and related methods
13 Jul 20
The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods.
Chandrashekar Giliyar, Srinivasan Venkateshwaran, Basawaraj Chickmath, Satish Kumar Nachaegari, Nachiappan Chidambaram, Mahesh V. Patel
Filed: 27 Mar 19
Utility
Testosterone Undecanoate Compositions
17 Jun 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage forms containing testosterone undecanoate, as well as related methods of treatment.
Basawaraj Chickmath, Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh V. Patel, Srinivasan Venkateshwaran
Filed: 12 Nov 19
Utility
Liver Disease
20 May 20
Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described.
Mahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari, Burke Byrne, Kilyoung Kim, Jonathan A. Baker
Filed: 18 Jul 19
Utility
Pharmaceutical Composition and Methods
20 May 20
Disclosed herein are compositions having a lipophilic active agent and methods of their use.
Mahesh Patel, Nachiappan Chidambaram, Satish Nachaegari, Srinivasan Venkateshwaran, Joel Frank, Chandrashekar Giliyar
Filed: 6 Oct 19
Utility
High-strength testosterone undecanoate compositions
18 May 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 16 Apr 18
Utility
High-strength Testosterone Undecanoate Compositions
4 Mar 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods.
Chandrashekar Giliyar, Basawaraj Chickmath, Nachiappan Chidambaram, Mahesh V. Patel, Srinivansan Venkateshwaran
Filed: 7 Nov 19
Utility
Pharmaceutical Compositions with Synchronized Solubilizer Release
4 Mar 20
Pharmaceutical compositions with synchronized solubilizer release as well as various methods associated therewith, are disclosed and described.
David T. Fikstad, Chandrashekar Giliyar, Srinivasan Venkateshwaran, Mahesh V. Patel
Filed: 13 Jun 19
Utility
Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
26 Feb 20
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered.
Mahesh V. Patel
Filed: 27 Feb 19
Utility
Testosterone undecanoate compositions
17 Feb 20
The present disclosure is drawn to pharmaceutical compositions and oral dosage forms containing testosterone undecanoate, as well as related methods of treatment.
Basawaraj Chickmath, Chandrashekar Giliyar, Nachiappan Chidambaram, Mahesh Patel, Srinivasan Venkateshwaran
Filed: 28 Sep 14
Utility
Bioavailable Solid State (17- β)-HYDROXY-4-ANDROSTEN-3-ONE Esters
12 Feb 20
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.
Mahesh V. Patel, Nachiappan Chidambaram, Satish Kumar Nachaegari, Srinivasan Venkateshwaran, Joel Frank
Filed: 11 Feb 19
Utility
Liver Disease
22 Jan 20
Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described.
Mahesh V. Patel, Nachiappan Chidambaram, Satish K. Nachaegari, Burke Byrne, Kilyoung Kim, Jonathan A. Baker
Filed: 27 Aug 19
Utility
(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
25 Dec 19
Disclosed herein are compositions having a lipophilic active agent and methods of their use.
Mahesh V. Patel, Nachiappan Chidambaram, Satish Kumar Nachaegari, Srinivansan Venkateshwaran, Joel Frank, Amy Jo Portlock
Filed: 29 May 19
Patents are sorted by USPTO publication date, most recent first